Javier Gonzalez-Garcia
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
In vitro and in vivo activity of daptomycin plus ceftaroline for the treatment of experimental endocarditis due to Enterococcus faecalis with and without high-level aminoglycoside resistance.
Journal: The Journal of antimicrobial chemotherapy
Published: November 12, 2025
In vitro exebacase (CF-301) activity against methicillin-susceptible or methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci strains isolated from patients with infective endocarditis.
Journal: The Journal of antimicrobial chemotherapy
Published: July 25, 2025
Time to Reappraise the Antibiotic Treatment for Methicillin-Susceptible Staphylococcus aureus Infective Endocarditis: Data From the Experimental Model.
Journal: The Journal of infectious diseases
Published: November 21, 2024
In Vitro Activity of Ampicillin Plus Ceftriaxone Against Non-faecalis and Non-faecium Enterococcal Isolates With/Without VanC Phenotype: Clinical Implications for Infective Endocarditis.
Journal: Microorganisms
Published: November 06, 2024
Efficacy of linezolid in monotherapy q12h versus q8h versus combined with daptomycin in the treatment of experimental endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus strains.
Journal: The Journal of antimicrobial chemotherapy
Published: October 21, 2024
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin.
Journal: Expert review of anti-infective therapy
Published: February 06, 2023
Relationship among Streptococcus gallolyticus Subsp. gallolyticus, Enterococcus faecalis and Colorectal Neoplasms in Recurrent Endocarditis: A Historical Case Series.
Journal: Journal of clinical medicine
Published: March 15, 2022
Development of High-Level Daptomycin Resistance in Abiotrophia and Granulicatella Species Isolates from Patients with Infective Endocarditis.
Journal: Antimicrobial agents and chemotherapy
Published: July 12, 2021
Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis.
Journal: The Journal of antimicrobial chemotherapy
Published: August 14, 2020
Cloxacillin or fosfomycin plus daptomycin combinations are more active than cloxacillin monotherapy or combined with gentamicin against MSSA in a rabbit model of experimental endocarditis.
Journal: The Journal of antimicrobial chemotherapy
Published: December 24, 2019
Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens.
Journal: Antimicrobial agents and chemotherapy
Published: March 08, 2019
The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis.
Journal: Antimicrobial agents and chemotherapy
Published: December 29, 2017
Last Updated: 09/26/2026